Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine

Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine

<b>Background:</b> Non-small-cell lung cancer (NSCLC) is one of the most frequently diagnosed diseases among all types of lung cancer. Infectious diseases contribute to morbidity and mortality by delaying appropriate anti-cancer therapy in patients with NSCLC. <b>Methods:</b>...

Full description

Bibliographic Details
Main Authors: Jolanta Smok-Kalwat, Paulina Mertowska, Izabela Korona-Głowniak, Sebastian Mertowski, Paulina Niedźwiedzka-Rystwej, Dominika Bębnowska, Krzysztof Gosik, Andrzej Stepulak, Stanisław Góźdź, Jacek Roliński, Zofia Górecka, Jan Siwiec, Ewelina Grywalska
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Journal of Clinical Medicine
Subjects:
non-small-cell lung cancer
immune system
13-valent pneumococcal conjugate vaccine
<i>Streptococcus pneumoniae</i>
vaccination
Online Access:https://www.mdpi.com/2077-0383/13/5/1520

Internet

https://www.mdpi.com/2077-0383/13/5/1520

Similar Items